(Q53140967)

English

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

scientific article published on 9 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Iver Nordentoft

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

16

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

object named as

Mads Agerbaek

7

0 references

Jørgen B Jensen

object named as

Jørgen B Jensen

14

0 references

11

object named as

Rainer Fietkau

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

12

object named as

Claus Rödel

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

8

object named as

Arndt Hartmann

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

author name string

Jens R Laurberg

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Anne S Brems-Eskildsen

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Niels Fristrup

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Troels Schepeler

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Benedicte P Ulhøi

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Simone Bertz

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Michael Wittlinger

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Michael Borre

13

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Torben Orntoft

15

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

publication date

9 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

110

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

11 Pt C

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

E1228-36

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Tip60: connecting chromatin to DNA damage signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

The combined status of ATM and p53 link tumor development with therapeutic response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Trimodality treatment and selective organ preservation for bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

ATM activation in normal human tissues and testicular cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

The MRE11 complex: starting from the ends.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Technical pitfalls potentially affecting diagnoses in immunohistochemistry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11564.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2012.11564.X

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23046361

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53140967&oldid=1879001119"